Soros Fund Management’s Fortress Biotech FBIO Stock Holding History

Soros Fund Management’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1,952	Closed	-$50K	–	285
2014 Q2	$50K	Buy	+1,952	New	+$51.5K	﹤0.01%	359

Other funds holding FBIO

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Soros Fund Management's FBIO Position: Q3 2014 in Review

Soros Fund Management sold out of Fortress Biotech (FBIO) in Q3 2014, closing a stake of 1,952 shares — an estimated $50K sold.

Soros Fund Management first reported a position in FBIO in Q2 2014 and held it in 1 quarter. The position peaked at $50K in Q2 2014. 39 funds tracked by Wall St. Rank hold FBIO as of Q3 2014.

Soros Fund Management reported no remaining Fortress Biotech position as of Q3 2014 after selling out during the quarter.
Soros Fund Management sold 1,952 Fortress Biotech shares in Q3 2014, an estimated $50K.
Soros Fund Management first reported a position in Fortress Biotech in Q2 2014 and held it in 1 quarter.
Soros Fund Management's Fortress Biotech position peaked at $50K in Q2 2014.
39 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2014.

Based on Soros Fund Management's 13F filing for Q3 2014, filed 14 Nov 2014.